Exploring blast composition in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms: CD45RA and CD371 improve diagnostic value of flow cytometry through assessment of myeloblast heterogeneity and stem cell aberrancy

BACKGROUND: Flow cytometry immunophenotyping (FCIP) can improve diagnosis of myelodysplastic syndromes (MDS) and myelodysplastic/myeloproliferative neoplasms (MDS/MPN), although its application is challenging due to difficulties in standardization, complexity of antibody panels and subjective interp...

Descripción completa

Detalles Bibliográficos
Autores principales: Shameli, Afshin, Dharmani‐Khan, Poonam, Luider, Joanne, Auer, Iwona, Shabani‐Rad, Meer‐Taher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519034/
https://www.ncbi.nlm.nih.gov/pubmed/33369070
http://dx.doi.org/10.1002/cyto.b.21983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519034/
https://www.ncbi.nlm.nih.gov/pubmed/33369070
http://dx.doi.org/10.1002/cyto.b.21983

Ejemplares similares